arrow
K

Karen L. Kotloff

University of Maryland School of Medicine
H指数:82
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Vulnerability to climate-driven pathogen-specific diarrheal diseases: secondary analysis from the Global Enteric Multicenter Study and Vaccine Impact on Diarrhea in Africa follow-up

作者更正:气候驱动下特定病原体介导的腹泻疾病的脆弱性:基于全球肠道多中心研究和非洲腹泻疫苗影响随访研究的二次分析

2026-11-160
OAAI
Vulnerability to climate-driven pathogen-specific diarrheal diseases: secondary analysis from the Global Enteric Multicenter Study and Vaccine Impact on Diarrhea in Africa follow-up

气候变化驱动的病原体特异性腹泻疾病的易感性:基于全球肠道多中心研究和非洲腹泻疫苗影响随访研究的二次分析

2026-08-060
OA
Persistence of Serum Bactericidal Antibody in the First 2 Years After Immunization With Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and Toddlers

在马拉维婴儿和幼儿中,接种五价脑膜炎球菌ACWYX疫苗后2年内血清杀菌抗体的持久性

2026-07-220
PRE
The consequences of Shigella medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study

在高负担地区居住的幼儿中,志贺氏菌医学就诊性腹泻及其他主要病原体的后果:一项多国前瞻性队列研究

2026-06-010
OAAI
Comparison of causes of stillbirth and child deaths as determined by verbal autopsy and minimally invasive tissue sampling (vol 2024, e0003065, 2024)

比较死产和儿童死亡原因的口述尸检与微创组织采样方法(卷 2024, e0003065, 2024)

2025-12-050
OAAI
An intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial

一种鼻内佐剂重组甲型流感病毒A/H5疫苗可针对多种H5N1亚系产生初始免疫应答:一项I期临床试验

2025-11-060
OAAI
Whole-genome analysis of rotavirus G1P[8] and other Wa-like strains in Mozambican children: evidence of genetic variations of pre-vaccine G1P[8] strains from Manhiça, Mozambique

莫桑比克儿童中轮状病毒G1P[8]及其他Wa-like毒株的全基因组分析:来自莫桑比克马尼卡(Manhiça)的疫苗前G1P[8]毒株存在遗传变异的证据

2025-10-010
PRE
Major Causes of Perinatal and Paediatric Mortality in Sub-Saharan Africa and South Asia: Adjustment for Selection Bias in the CHAMPS Network

撒哈拉以南非洲和南亚围产期及儿科死亡的主要病因:CHAMPS网络中针对选择偏倚的调整

2025-09-040
OAAI
Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)

NVX-CoV2373四次序贯剂量的安全性与免疫原性:一项在成人和青少年中进行的3期、随机、安慰剂对照试验(PREVENT-19)

Vaccine
IF3.5
2025-07-080
OA
Adherence to Perinatal Asphyxia or Sepsis Management Guidelines in Low- and Middle-Income Countries

低收入和中等收入国家对围产期窒息或败血症管理指南的遵循情况

2025-05-160
OA
WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries

WHO 工作坊报告:为低收入和中等收入国家儿童使用的志贺氏菌疫苗提供临床路径的监管科学

2025-04-230
OA
Investigating the Role of Cytomegalovirus as a Cause of Stillbirths and Child Deaths in Low- and Middle-Income Countries Through Postmortem Minimally Invasive Tissue Sampling
2025-04-010
PRE
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3 observer-blinded, randomised, placebo-controlled trial

NVX-CoV2373疫苗在美国青少年中针对SARS-CoV-2感染的效力:一项附加于观察者盲法、随机、安慰剂对照III期试验的研究

2025-01-010
OAAI
Genomic analysis of DS-1-like human rotavirus A strains uncovers genetic relatedness of NSP4 gene with animal strains in Manhiça District, Southern Mozambique
2024-12-280
OAAI
Contribution of malnutrition to infant and child deaths in Sub-Saharan Africa and South Asia
2024-12-051
OAAI